1111638-02-8

Basic information

• Product Name: 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine
• Synonyms: 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine;5-Bromo-2-methyl-7-Azaindole;5-Bromo-2-methyl-7-Azaind...;5-Bromo-2-iodo-1H-pyrrolo[2,3-b]pyridine;1H-Pyrrolo[2,3-b]pyridine, 5-broMo-2-Methyl-
• CAS NO: 1111638-02-8
• Molecular Formula: C₈H₇BrN₂
• Molecular Weight: 211.05858
• Product Categories: Azaindoles
• Mol File: 1111638-02-8.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 320.567 °C at 760 mmHg
• Flash Point: 147.674 °C
• Appearance: /
• Density: 1.654
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.49±0.40(Predicted)
• CAS DataBase Reference: 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine(1111638-02-8)
• EPA Substance Registry System: 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine(1111638-02-8)

Safety Data

• Hazard Codes: Xn
• Statements: 22-41
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 1111638-02-8(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine is a chemical compound with the molecular formula C8H7BrN2. It is a heterocyclic compound that consists of a pyrrole ring fused to a pyridine ring with a methyl and a bromine substituent. 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine has potential applications in pharmaceutical and agrochemical fields due to its structural features, which make it a valuable building block for the synthesis of biologically active molecules. Additionally, it has been studied for its potential use in the development of new materials and organic electronic devices. 5-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine is a versatile compound with promising properties for various industrial and research applications.

InChI:InChI=1S/C8H7BrN2/c1-5-2-6-3-7(9)4-10-8(6)11-5/h2-4H,1H3,(H,10,11)

Upstream product

• 1001070-33-2 1-(benzenesulfonyl)-5-bromo-1H-pyrrolo[2,3-b]pyridine 
• 183208-35-7 5-bromo-1H-pyrrolo[2,3-b]pyridine 
• 1312755-43-3 5-bromo-3-(prop-1-yn-1-yl)pyridin-2-amine 
• 1072-97-5 5-bromo-2-pyridylamine 
• 381233-96-1 2-amino-3-iodo-5-bromopyridine 
• 1111638-01-7 5-bromo-2-methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 1111638-03-9 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 
• 1228551-75-4 5-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid methyl ester 
• 1200130-70-6 9-benzenesulfonyl-5-hydroxy-9H-dipyrido[2,3-b:4',3'-d]pyrrole-6-carbonitrile 
• 1200130-72-8 1-benzenesulfonyl-5-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid methyl ester 
• 1200130-73-9 1-benzenesulfonyl-5-bromo-2-bromomethyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid methyl ester 
• 1200130-74-0 1-benzenesulfonyl-5-bromo-2-{[cyanomethyl-(toluene-4-sulfonyl)amino]methyl}-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid methyl ester 
• 1200130-75-1 9-benzenesulfonyl-3-bromo-5-hydroxy-9H-dipyrido[2,3-b:4',3'-d]pyrrole-6-carbonitrile 
• 1200132-31-5 9-benzenesulfonyl-3-bromo-5-(piperidin-4-yloxy)-9H-dipyrido[2,3-b:4',3'-d]pyrrole-6-carbonitrile 
• 1312755-44-4 9-benzenesulfonyl-3-bromo-5-chloro-9H-dipyrido[2,3-b;4',3'-d]pyrrole-6-carbonitrile 
• 1312756-21-0 4-(9-benzenesulfonyl-3-bromo-6-cyano-9H-dipyrido[2,3-b;4',3'-d]pyrrol-5-yloxy)piperidine-1-carboxylic acid tert-butyl ester 
• 1312756-22-1 9-benzenesulfonyl-3-bromo-5-[1-(2,2-difluoroethyl)-piperidin-4-yloxy]-9H-dipyrido[2,3-b;4',3'-d]pyrrole-6-carbonitrile 
• 1312756-23-2 9-benzenesulfonyl-5-[1-(2,2-difluoroethyl)-piperidin-4-yloxy]-9H-dipyrido[2,3-b;4',3'-d]pyrrole-6-carbonitrile 
• 1312756-24-3 9-benzenesulfonyl-3-bromo-5-[1-(2-methanesulfonylethyl)-piperidin-4-yloxy]-9H-dipyrido[2,3-b;4',3'-d]pyrrole-6-carbonitrile 
• 1312756-25-4 9-benzenesulfonyl-5-[1-(2-methanesulfonylethyl)-piperidin-4-yloxy]-9H-dipyrido[2,3-b;4',3'-d]pyrrole-6-carbonitrile 

Relevant articles and documents

AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR

A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.

COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION

The invention relates to a bromodomain inhibitor. The invention also provides compositions and formulations comprising such compounds, and methods of using and preparing such compounds.

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma

Further optimization of an initial DP2 receptor antagonist clinical candidate NVP-QAV680 led to the discovery of a follow-up molecule 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid (compou